Sintx Technologies Reports Q2 2024 Results, Revenue Declines
Ticker: SINT · Form: 10-Q · Filed: Aug 13, 2024 · CIK: 1269026
| Field | Detail |
|---|---|
| Company | Sintx Technologies, Inc. (SINT) |
| Form Type | 10-Q |
| Filed Date | Aug 13, 2024 |
| Risk Level | medium |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | bearish |
Sentiment: bearish
Topics: revenue-decline, net-loss, quarterly-results, medical-devices
TL;DR
SINT revenue down in Q2, losses widening. Uh oh.
AI Summary
Sintx Technologies, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported revenue of $1.1 million for the three months ended June 30, 2024, a decrease from $1.3 million in the same period of 2023. For the six months ended June 30, 2024, revenue was $2.1 million, down from $2.5 million in the prior year. The company's net loss for the second quarter of 2024 was $2.1 million, compared to a net loss of $1.7 million in the second quarter of 2023.
Why It Matters
The decline in revenue and increase in net loss for Sintx Technologies in Q2 2024 indicates potential challenges in sales performance and profitability, which could impact investor confidence and future growth prospects.
Risk Assessment
Risk Level: medium — The company's declining revenues and increasing net losses suggest potential financial instability and operational challenges.
Key Numbers
- $1.1M — Q2 2024 Revenue (Down from $1.3M in Q2 2023.)
- $2.1M — YTD 2024 Revenue (Down from $2.5M YTD 2023.)
- $2.1M — Q2 2024 Net Loss (Increased from $1.7M in Q2 2023.)
Key Players & Entities
- Sintx Technologies, Inc. (company) — Filer of the 10-Q report.
- June 30, 2024 (date) — End of the reporting period for the 10-Q.
- $1.1 million (dollar_amount) — Revenue for the three months ended June 30, 2024.
- $1.3 million (dollar_amount) — Revenue for the three months ended June 30, 2023.
- $2.1 million (dollar_amount) — Revenue for the six months ended June 30, 2024.
- $2.5 million (dollar_amount) — Revenue for the six months ended June 30, 2023.
- $2.1 million (dollar_amount) — Net loss for the second quarter of 2024.
- $1.7 million (dollar_amount) — Net loss for the second quarter of 2023.
FAQ
What was Sintx Technologies' total revenue for the second quarter of 2024?
Sintx Technologies reported total revenue of $1.1 million for the three months ended June 30, 2024.
How did the revenue for the first six months of 2024 compare to the same period in 2023?
Revenue for the six months ended June 30, 2024, was $2.1 million, a decrease from $2.5 million for the six months ended June 30, 2023.
What was the net loss for Sintx Technologies in the second quarter of 2024?
The company reported a net loss of $2.1 million for the second quarter of 2024.
How does the Q2 2024 net loss compare to the Q2 2023 net loss?
The net loss for the second quarter of 2024 was $2.1 million, an increase from the net loss of $1.7 million in the second quarter of 2023.
What is the company's primary business segment based on the SIC code?
Sintx Technologies, Inc. is classified under SIC code 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 4,807 words · 19 min read · ~16 pages · Grade level 14.3 · Accepted 2024-08-13 16:32:31
Filing Documents
- form10-q.htm (10-Q) — 936KB
- ex31-1.htm (EX-31.1) — 12KB
- ex31-2.htm (EX-31.2) — 12KB
- ex32.htm (EX-32) — 7KB
- 0001493152-24-031644.txt ( ) — 5105KB
- sint-20240630.xsd (EX-101.SCH) — 40KB
- sint-20240630_cal.xml (EX-101.CAL) — 53KB
- sint-20240630_def.xml (EX-101.DEF) — 177KB
- sint-20240630_lab.xml (EX-101.LAB) — 353KB
- sint-20240630_pre.xml (EX-101.PRE) — 265KB
- form10-q_htm.xml (XML) — 736KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 19
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 27
Controls and Procedures
Item 4. Controls and Procedures 27
Other Information
Part II. Other Information
Legal Proceedings
Item 1. Legal Proceedings 28
Risk Factors
Item 1A. Risk Factors 28
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities 28
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 28
Other Information
Item 5. Other Information 28
Exhibits
Item 6. Exhibits 29
Signatures
Signatures 30 2 SINTX Technologies, Inc. Condensed Consolidated Balance Sheets - Unaudited (in thousands, except share and per share data) June 30, 2024 December 31, 2023 Assets Current assets: Cash and cash equivalents $ 4,557 $ 3,340 Account and other receivables, net of allowance totaling 68 and 72 respectively 434 685 Prepaid expenses and other current assets 384 539 Inventories 445 888 Other current assets 41 80 Total current assets 5,861 5,532 Inventories, net 575 333 Property and equipment, net 4,815 4,826 Intangible assets, net 19 21 Operating lease right of use asset 3,791 4,094 Other long-term assets 235 559 Total assets $ 15,296 $ 15,365 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 331 $ 636 Accrued liabilities 1,558 1,404 Debt 241 46 Derivative liabilities 397 304 Current portion of operating lease liability 494 512 Other current liabilities - 4 Total current liabilities 3,021 2,906 Operating lease liability, net of current portion 3,429 3,687 Total liabilities 6,450 6,593 Commitments and contingencies - - Stockholders' equity: Convertible preferred stock Series B, $ 0.01 par value, 130,000,000 total shares authorized inclusive of all series of preferred; 15 and 26 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. - - Convertible preferred stock Series C, $ 0.01 par value, 130,000,000 total shares authorized inclusive of all series of preferred; 50 shares issued and outstanding as of June 30, 2024 and December 31, 2023. - - Convertible preferred stock Series D, $ 0.01 par value, 130,000,000 total shares authorized inclusive of all series of preferred; 180 shares issued and outstanding as of June 30, 2024 and December 31, 2023. - - Preferred stock value - - Common stock, $ 0.01 par value, 250,000,000 shares authorized; 748,341 and 26,603 shares issued and outsta